CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.2.3. Top Winning Strategies, By Company, 2015-2017

3.3. PORTERS FIVE FORCE ANALYSIS
3.4. GOVERNMENT REGULATIONS

3.4.1. U.S.
3.4.1. Europe

3.5. INSURANCE REIMBURSEMENT SCENARIO
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Continuous decline in fertility rates
3.6.1.2. Delayed pregnancies in women
3.6.1.3. Technological advancements with respect to fertility treatment

3.6.2. Restraints

3.6.2.1. High treatment costs of ARTs in developed countries
3.6.2.2. Inadequate reimbursement policies

3.6.3. Opportunity

3.6.3.1. Rise in fertility tourism

CHAPTER 4 FERTILITY SERVICES MARKET, BY PROCEDURE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. IVF WITH ICSI

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. IUI

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. IVF WITHOUT ICSI

4.4.1. Key market trends growth factors, and opportunities
4.4.2. Market size and forecast

4.5. SURROGACY

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast

4.6. OTHERS

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast

CHAPTER 5 FERTILITY SERVICES MARKET, BY SERVICE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. FRESH NON-DONOR

5.2.1. Market size and forecast

5.3. FROZEN NON-DONOR

5.3.1. Market size and forecast

5.4. EGG AND EMBRYO BANKING

5.4.1. Market size and forecast

5.5. FRESH DONOR

5.5.1. Market size and forecast

5.6. FROZEN DONOR

5.6.1. Market size and forecast

CHAPTER 6 FERTILITY SERVICES MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. FERTILITY CLINICS

6.2.1. Market size and forecast

6.3. HOSPITALS

6.3.1. Market size and forecast

6.4. SURGICAL CENTERS

6.4.1. Market size and forecast

6.5. CLINICAL RESEARCH INSTITUTES

6.5.1. Market size and forecast

CHAPTER 7 FERTILITY SERVICES MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by procedure
7.2.4. Market size and forecast, by service
7.2.5. Market size and forecast, by end user

7.2.5.1. U.S. market size and forecast
7.2.5.2. Canada size and forecast
7.2.5.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by procedure
7.3.4. Market size and forecast, by service
7.3.5. Market size and forecast, by end user

7.3.5.1. Germany market size and forecast
7.3.5.2. France market size and forecast
7.3.5.3. UK market size and forecast
7.3.5.4. Italy market size and forecast
7.3.5.5. Spain market size and forecast
7.3.5.6. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by procedure
7.4.4. Market size and forecast, by service
7.4.5. Market size and forecast, by end user

7.4.5.1. Japan market size and forecast
7.4.5.2. India market size and forecast
7.4.5.3. China market size and forecast
7.4.5.4. Australia market size and forecast
7.4.5.5. South Korea market size and forecast
7.4.5.6. Taiwan market size and forecast
7.4.5.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by procedure
7.5.4. Market size and forecast, by service
7.5.5. Market size and forecast, by end user

7.5.5.1. Brazil market size and forecast
7.5.5.2. Turkey market size and forecast
7.5.5.3. Saudi Arabia market size and forecast
7.5.5.4. South Africa market size and forecast
7.5.5.5. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. APOLLO HOSPITALS ENTERPRISE LTD.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. CARE FERTILITY GROUP

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Key strategic moves and developments

8.3. CAROLINAS FERTILITY INSTITUTE

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio

8.4. GENEA LIMITED

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments

8.5. THE JOHNS HOPKINS HEALTH SYSTEM CORP.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio

8.6. MEDICOVER GROUP

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. MONASH IVF GROUP

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance

8.8. OVASCIENCE INC.

8.8.1. Company overview
8.8.2. Product portfolio
8.8.3. Business performance
8.8.4. Key strategic moves and developments

8.9. PROGYNY INC.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Key strategic moves and developments

8.10. XYTEX CRYO INTERNATIONAL

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Product portfolio